Literature DB >> 19626293

[Economic public health significance of generic drugs].

Doris Tschabitscher, Fabian Waechter, Marcus Müllner.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19626293     DOI： 10.1007/s00508-009-1177-8

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN： 0043-5325            Impact factor:   1.704


× No keyword cloud information.
  9 in total

1.  [Cost reduction with project based prescription of generic ACE inhibitors].

Authors:  Michael Wolzt; Gerald Ohrenberger; Berthold Reichardt
Journal:  Wien Klin Wochenschr       Date:  2003-01-31       Impact factor: 1.704

2.  The influence of big pharma.

Authors:  R E Ferner
Journal:  BMJ       Date:  2005-04-16

3.  Doctors and drug companies--scrutinizing influential relationships.

Authors:  Eric G Campbell
Journal:  N Engl J Med       Date:  2007-11-01       Impact factor: 91.245

4.  The quantity and quality of worldwide new drug introductions, 1982-2003.

Authors:  Henry G Grabowski; Y Richard Wang
Journal:  Health Aff (Millwood)       Date:  2006 Mar-Apr       Impact factor: 6.301

5.  [Partial reimbursement of prescription charges for generic drugs reduces costs for both health insurance and patients].

Authors:  Ghazaleh Gouya; Berthold Reichardt; Anja Bidner; Robert Weissenfels; Michael Wolzt
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

6.  Balancing Big Pharma's books.

Authors:  Andrew Jack
Journal:  BMJ       Date:  2008-02-23

7.  The ongoing regulation of generic drugs.

Authors:  Richard G Frank
Journal:  N Engl J Med       Date:  2007-11-15       Impact factor: 91.245

8.  Prescription drug spending trends in the United States: looking beyond the turning point.

Authors:  Murray Aitken; Ernst R Berndt; David M Cutler
Journal:  Health Aff (Millwood)       Date:  2008-12-16       Impact factor: 6.301

9.  [Generic drugs: quality, efficacy, safety and interchangeability].

Authors:  Doris Tschabitscher; Peter Platzer; Christoph Baumgärtel; Marcus Müllner
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.